Acute phase markers for the differentiation of infectious and malignant pleural effusions

被引:52
作者
Kiropoulos, Theodoros S. [1 ]
Kostikas, Konstantinos
Oikonomidi, Smaragda
Tsilioni, Irene
Nikoulis, Dimitrios
Germenis, Anastasios
Gourgoulianis, Konstantinos I.
机构
[1] Univ Thessaloniki, Univ Hosp Larissa, Sch Med, Dept Resp Med, Larisa 41110, Greece
[2] Univ Thessaloniki, Univ Hosp Larissa, Sch Med, Dept Immunol & Histocompatibil, Larisa 41110, Greece
关键词
acute phase response markers; C-reactive protein; interleukin-6; pleural effusion; tumor necrosis factor alpha;
D O I
10.1016/j.rmed.2006.09.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute-phase markers, such as C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-a), have been studied in inflammatory and malignant disorders. We examined the diagnostic value of these markers for the differentiation among parapneumonic, tuberculous and malignant effusions. We studied 124 patients with pleural effusions, classified as exudates [total (n = 97), parapneumonic (n = 15), tuberculous (n = 25), malignant (n = 57)] and transudates due to congestive heart failure (n = 27). CRP, IL-6 and TNF-alpha were measured in pleural fluid and serum. Pleural fluid CRP was higher in parapneumonic compared to tuberculous and malignant effusions, providing 100% sensitivity for a cut-off point of 5.3 mg/dL. IL-6 was higher in both parapneumonic and tuberculous compared to malignant effusions. TNF-alpha was higher in tuberculous compared to malignant effusions, providing 96.0% sensitivity, and 93.0% specificity for a cut-off point of 88.1 pg/mL. Pleural fluid CRP levels were tower than serum in all groups, probably reflecting systemic inflammation, whereas IL-6 and TNF-a were higher in pleural fluid indicating local production. Our data suggest that these markers may provide useful information for the differentiation of infectious and malignant effusions in clinical practice. However, further studies are needed for the validation of these findings in usual clinical circumstances. (C) 2006 Published by Elsevier Ltd.
引用
收藏
页码:910 / 918
页数:9
相关论文
共 32 条
[1]  
Alegre J, 1999, AM J RESP CRIT CARE, V159, pA385
[2]   Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions [J].
Alemán, C ;
Alegre, J ;
Monasterio, J ;
Segura, RM ;
Armadans, L ;
Anglés, A ;
Varela, E ;
Ruiz, E ;
De Sevilla, TF .
CLINICAL SCIENCE, 2003, 105 (05) :601-607
[3]  
[Anonymous], TAIWAN 21 CENTURY
[4]  
BALLOU SP, 1992, ADV INTERNAL MED, V37, P313
[5]  
BARNES PF, 1990, J IMMUNOL, V145, P149
[6]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[7]  
Castano Vidriales J L, 1992, Eur J Med, V1, P201
[8]   A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion [J].
Chierakul, N ;
Kanitsap, A ;
Chaiprasert, A ;
Viriyataveekul, R .
RESPIROLOGY, 2004, 9 (01) :66-69
[9]   Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454
[10]  
Garcia-Pachon E, 2002, Eur J Intern Med, V13, P246, DOI 10.1016/S0953-6205(02)00036-5